Company Overview and News

 
High stakes at the Hyatt: AMP board to face investors at AGM

2018-04-18 theage.com.au
AMP won’t have to wait long to feel the backlash from the appalling revelations that have emerged from the banking royal commission.
Upvote Downvote

 
High stakes at the Hyatt: AMP board to face investors at AGM

2018-04-18 smh.com.au
AMP won’t have to wait long to feel the backlash from the appalling revelations that have emerged from the banking royal commission.
Upvote Downvote

 
Another sponsor walks from Australian cricket team as big brands cut ties over ball-tampering scandal

2018-03-29 perthnow.com.au
MAGELLAN Financial Group has upped stumps as the naming rights sponsor of the Australian men’s domestic Test series following this week’s explosive ball-tampering scandal in South Africa.
Upvote Downvote

 
Magellan terminates partnership with Cricket Australia

2018-03-29 proactiveinvestors.com.au
Magellan Financial Group Ltd (ASX:MFG) has terminated its partnership with Cricket Australia, citing the ball tampering incident of the national men’s team in South Africa.
Upvote Downvote

 
UPDATE 2-Cricket-Cricket Australia loses major sponsor over players' 'conspiracy' to cheat

2018-03-29 reuters
SYDNEY (Reuters) - Australia’s Magellan Financial Group Ltd canceled a naming rights sponsorship deal with Cricket Australia after it banned players involved in a ball-tampering scandal, the biggest blow to the country’s governing body reeling from the incident.
Upvote Downvote

 
UPDATE 1-Cricket-Cricket Australia loses major sponsor over players' 'conspiracy' to cheat

2018-03-29 reuters
SYDNEY, March 29 (Reuters) - Australia’s Magellan Financial Group Ltd cancelled a naming rights sponsorship deal with Cricket Australia after it banned players involved in a ball-tampering scandal, the biggest blow to the country’s governing body reeling from the incident.
Upvote Downvote

 
Magellan dumps Cricket Australia sponsorship deal

2018-03-29 theage.com.au
Magellan Financial Group has terminated its three-year partnership as the naming rights sponsor of domestic Test matches involving the Australian men's cricket team, in response to the ball-tampering scandal in South Africa that has rocked Australian cricket.
Upvote Downvote

 
Magellan dumps Cricket Australia sponsorship deal

2018-03-29 smh.com.au
Magellan Financial Group has terminated its three-year partnership as the naming rights sponsor of domestic Test matches involving the Australian men's cricket team, in response to the ball-tampering scandal in South Africa that has rocked Australian cricket.
Upvote Downvote

 
'A shameful moment for Australian sport': Cricket sponsors hit out

2018-03-26 theage.com.au
Cricket sponsors have expressed disappointment and shock at the cheating scandal that has engulfed the Australian cricket team during the controversial Test series in South Africa, with Sanitarium saying the events were “a shameful moment for Australian sport”.
Upvote Downvote

 
'A shameful moment for Australian sport': Cricket sponsors hit out

2018-03-26 smh.com.au
Cricket sponsors have expressed disappointment and shock at the cheating scandal that has engulfed the Australian cricket team during the controversial Test series in South Africa, with Sanitarium saying the events were “a shameful moment for Australian sport”.
Upvote Downvote

 
Dumping of top stock-picker Sevior sounds alarm for money managers

2018-02-20 smh.com.au
A move by the country’s largest superannuation fund, Australian Super, to dump the fund run by high-profile stock-picker John Sevior underscores the challenges facing professional money managers on many fronts.
Upvote Downvote

 
Dumping of top stock-picker Seviour sounds alarm for money managers

2018-02-20 smh.com.au
A move by the country’s largest superannuation fund, Australian Super, to dump the fund run by high-profile stock-picker John Sevior underscores the challenges facing professional money managers on many fronts.
Upvote Downvote

 
Share dump is opportunity to make money say investment gurus

2018-02-06 theage.com.au
Australia's benchmark share index has fallen by about 5 per cent in two days wiping about $84 billion from the market's value but fund manager insist shareholders should remain calm.
Upvote Downvote

 
Share dump is opportunity to make money say investment gurus

2018-02-06 smh.com.au
Australia's benchmark share index has fallen by about 5 per cent in two days wiping about $84 billion from the market's value but fund manager insist shareholders should remain calm.
Upvote Downvote

 
US markets send Australian and other Asian bourses spiralling

2018-02-06 proactiveinvestors.com.au
A 4.6% circa 1,200 point fall in the Dow Jones index placed intense pressure on the S&P/ASX 200 (XJO).
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...